Abcam Abcam to Acquire Life Science Research Tool Firm BioVision for $340M BioVision, which has been supplying products to Abcam since 2003, generated $33.8 million in revenues last year. Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research Abcam will develop custom protein-based reagents for Abcam Acquires Marker Gene Technologies UK-based Abcam has acquired Oregon-based life science research tool provider Marker Gene Technologies, the latest in a string of asset purchases. Abcam Acquires Applied StemCell Gene Editing Platform, Oncology Product Line Abcam said that acquisition will help it build out a discovery engine for developing novel edited cell lines and support its knockout validation initiative. Expedeon to Sell Proteomics, Immunology Businesses to Abcam for $130M The deal includes Expedeon's core proteomics business, as well as its immunology-focused subsidiaries Innova Biosciences and TGR Biosciences. Nov 8, 2019 Abcam Inks Deal for BrickBio Antibody Conjugation Technology Jul 16, 2019 Abcam Acquires Knockout Cell Lines, Lysates Portfolio From EdiGene Apr 1, 2019 NanoString Signs on AbCam to Supply Antibody Panels for Spatial Profiling Platform May 9, 2018 Abcam Drops Takeover Bid for Horizon Discovery May 8, 2018 Horizon Discovery Preliminary 2017 Revenues Up 52 Percent May 2, 2018 Horizon Discovery Rejects £270M Takeover Offer From Abcam May 26, 2017 Abcam Applying Next-Gen Sequencing to Improve Antibody Development Premium Apr 21, 2017 Aptamers Working to Carve Out Niche in Affinity Reagent Space Premium Apr 8, 2016 AxioMx Continues Work on Speeding Antibody Development After Acquisition by Abcam Premium Nov 11, 2015 Abcam Acquiring AxioMx for $45M Sep 9, 2015 Horizon Discovery, Abcam Ink Licensing Deal Jan 26, 2015 Abcam Gains Multiplexing, miRNA Assays via Firefly Buy; Sees Opportunities in Protein Analysis Premium Jan 21, 2015 Abcam to Acquire Firefly BioWorks for $28M Sep 9, 2014 People in the News: Alan Hirzel, Jonathan Milner, Peter Keen, Louise Patten Premium Mar 30, 2012 New Products: AB Sciex's Academic Partnership Program and More Premium May 24, 2011 Abcam Buys MitoSciences for $6M Jul 16, 2010 New MIAPE Modules Cover Four Proteomic Areas, Offer Guidelines for Commercial Reagents Premium Apr 23, 2009 Asterand to Validate Abcam’s Antibodies Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.